"To support the Company’s continued investment in its core brands, GeneType, EasyDNA and AffinityDNA, and to secure further revenue growth, the Company expects to raise further equity. The Board are currently in discussions with equity advisors and will provide a further update to the market as appropriate."
What an interesting endeavor and at what price?
10% disc at vwap on last 20days trading, not at $5.50usd like last CR..
